Position in ALXO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,936,834
+$1,662,222 QoQ
Shares Held
935,669
+583.1% QoQ
Ownership
0.677%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 94 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. ALXO ranks #229 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ALXO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,936,834 | 935,669 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $274,612 | 136,964 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $168,478 | 149,097 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $174,142 | 95,160 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $56,402 | 135,909 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $198,227 | 318,183 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $572,918 | 343,066 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $581,929 | 319,742 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,474,641 | 244,551 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,734,112 | 245,212 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,630,776 | 243,840 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $919,315 | 191,524 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,447,191 | 192,702 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $897,477 | 198,557 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,287,031 | 202,931 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,773,068 | 289,767 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,617,885 | 199,986 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,935,426 | 173,694 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,735,068 | 173,805 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $12,900,681 | 174,664 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,352,465 | 171,040 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $12,981,925 | 176,050 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $10,348,050 | 120,047 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $4,370,895 | 115,816 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||